Sight Sciences, Inc. (SGHT) Financial Analysis & Valuation | Quarter Chart

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduc... more
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercia... more

Company facts

Reported company information and share structure.

Company Share structure
Market Cap$565.79MExchangeNASDAQ
SectorHealthcareIndustryMedical - Devices
CountryUSCEOPaul Badawi
IPO Date2021-07-15CAGR39.49%
Employees186Websitewww.sightsciences.com
Div. Yield—Payout Ratio—
Buy Back Yield—Total Yield—
SGHT chart loading...

Key metrics

Reported fundamentals and market-derived technical indicators.

Fundamentals Technicals
EV$508.82MP/E-18.18Forward P/E-28.36PEG—
P/S15.95P/B28.68P/CF-83.32P/FCF-83.29
Sales$88.39MSales 1Y16.23%Sales 3Y6.7%Sales 5Y104.32%
EPS$-0.56EPS 1Y-42.4%EPS 3Y-59.18%EPS 5Y-62.97%
Sales QoQ6.56%EPS QoQ50%Sales QoQ Avg6.08%EPS QoQ Avg34.61%
Gross Margin87.74%Operating Margin-29.52%Profit Margin-32.13%ROCE-30.77%
ROA-27%ROE-52%Altman Z Score1.69Piotroski Score3
Current Ratio5.04Quick Ratio4.72Cash Ratio3.84Op. CF Ratio-0.12
Debt/Equity0.86Debt/Assets0.4Lt Debt/Equity0.73Lt Debt/Cap.0.42
Intrst Cov.-9.95Inventory Turnover1.67Asset Turnover0.84Receivables Turnover6.61
Enterprise Value$508.82MP/E Ratio-18.18
Forward P/E-28.36PEG Ratio—
P/S Ratio15.95P/B Ratio28.68
P/CF Ratio-83.32P/FCF Ratio-83.29
EPS$-0.56EPS Growth 1Y-42.4%
EPS Growth 3Y-59.18%EPS Growth 5Y-62.97%
Revenue Growth 1Y16.23%Gross Margin87.74%
Operating Margin-29.52%Profit Margin-32.13%
ROE-52%ROA-27%
ROCE-30.77%Current Ratio5.04
Quick Ratio4.72Cash Ratio3.84
Debt/Equity0.86Interest Coverage-9.95
Altman Z Score1.69Piotroski Score3